πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8084199

Method of diagnosing poor survival prognosis colon cancer using microRNA-21

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8080554

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075903

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076100

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076372

Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

The Government of the United States Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075900

Melanoma associated peptide analogues and vaccines against melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075921

Rapamycin-resistant T cells and therapeutic uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071113

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071746

Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071084

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071323

Human monoclonal antibodies that bind human insulin like growth factors and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067530

Scytovirin domain 1 related polypeptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067202

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067563

Tumor suppressor gene, p471NG3

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8063195

Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8063209

Phosphonyl ester conjugates as prodrugs

The United States of America as represented by the Department of Health and Human Services (DHHS) Β· Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8058249

Immunostimulatory nucleic acid molecules

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8058248

Foot and mouth disease virus vaccine comprising interferons

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8053487

Multifunctional acrylates used as cross-linkers in dental and biomedical self-etching bond

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8053422

Anti-cancer oligodeoxynucleotides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8053443

N-substituted indenoisoquinolines and syntheses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8048432

Polysaccharide-protein conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8048427

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8044185

Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to revea

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted